Trichocytes are specialized cells associated with certain venomous animals, particularly in the phylum Cnidaria, which includes jellyfish, anemones, and corals. These cells are part of structures known as nematocysts or cnidocytes, which are responsible for delivering toxins to capture prey or deter predators. Trichocytes have a tubular structure, and each cell contains a long, coiled filament connected to a capsule. When triggered by mechanical or chemical stimuli, the trichocyte rapidly ejects the filament from the capsule, injecting venom into the target organism. The venom typically contains a mix of proteins and toxins that immobilize or incapacitate the prey or threat. In jellyfish, trichocytes are concentrated in the tentacles, where they play a crucial role in capturing and subduing prey. The discharge of nematocysts is a rapid and effective mechanism for jellyfish to secure food. Understanding the structure and function of trichocytes is essential for researchers studying venomous animals and their ecological roles. Additionally, the toxins produced by trichocytes have been of interest in medical research, as they can potentially be used for the development of pharmaceuticals or understanding neurotoxic mechanisms. Overall, trichocytes exemplify the fascinating adaptations that have evolved in certain organisms for survival and predation.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States